Rainbow Children’s Medicare Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1017.5
- Today's High:
- ₹1048.65
- Open Price:
- ₹1048.65
- 52W Low:
- ₹413.2
- 52W High:
- ₹912
- Prev. Close:
- ₹1025.25
- Volume:
- 18818
Company Statistics
- Market Cap.:
- ₹0
- Book Value:
- 57.757
- Revenue TTM:
- ₹8.53 billion
- Operating Margin TTM:
- 20.03%
- Gross Profit TTM:
- ₹4.24 billion
- Profit Margin:
- 11.45%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Rainbow Children’s Medicare Ltd had its IPO on under the ticker symbol RAINBOW.
The company operates in the sector and industry. Rainbow Children’s Medicare Ltd has a staff strength of 3,496 employees.
Stock update
Shares of Rainbow Children’s Medicare Ltd opened at ₹1048.65 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1017.5 - ₹1048.65, and closed at ₹1018.8.
This is a -0.63% slip from the previous day's closing price.
A total volume of 18,818 shares were traded at the close of the day’s session.
In the last one week, shares of Rainbow Children’s Medicare Ltd have slipped by -2.59%.
Rainbow Children’s Medicare Ltd's Key Ratios
Rainbow Children’s Medicare Ltd has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Rainbow Children’s Medicare Ltd’s revenue was ₹8.53 billion with a gross profit of ₹4.24 billion and an EBITDA of ₹2.20 billion. The EBITDA ratio measures Rainbow Children’s Medicare Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Rainbow Children’s Medicare Ltd’s operating margin was 20.03% while its return on assets stood at 0% with a return of equity of 0%.
In Q3, Rainbow Children’s Medicare Ltd’s quarterly earnings growth was a positive 244.8% while revenue growth was a positive 65.5%.
Rainbow Children’s Medicare Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 86.7683
- PEG
Its diluted EPS in the last 12-months stands at ₹10.369 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Rainbow Children’s Medicare Ltd’s profitability.
Rainbow Children’s Medicare Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Rainbow Children’s Medicare Ltd stock pays annual dividends of ₹1 per share, indicating a yield of 0.12% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹0
- Total Liabilities
- ₹0
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Rainbow Children’s Medicare Ltd ended 2024 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.
Rainbow Children’s Medicare Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Rainbow Children’s Medicare Ltd’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.
In 2024, Rainbow Children’s Medicare Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Rainbow Children’s Medicare Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1018.8
- 52-Week High
- ₹912
- 52-Week Low
- ₹413.2
- Analyst Target Price
- ₹
Rainbow Children’s Medicare Ltd stock is currently trading at ₹1018.8 per share. It touched a 52-week high of ₹912 and a 52-week low of ₹912. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1061.27 and 200-day moving average was ₹861.43 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Rainbow Children’s Medicare Ltd
Most Active
Top Gainers
Top Losers
About
Rainbow Children’s Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company’s child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women’s nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.